Glibenclamide decelerates the responses of coronary regulation in the goat
| Autor: | J. Dankelman, J. A. E. Spaan, C. P. B. Van Der Ploeg |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
medicine.medical_specialty
Potassium Channels Time Factors Physiology Systole Partial Pressure Blood Pressure Muscle Smooth Vascular Ventricular Function Left Glibenclamide Oxygen Consumption Heart Rate Physiology (medical) Internal medicine Coronary Circulation Heart rate Glyburide medicine Animals Homeostasis Complete response Chemistry Goats Blood flow Coronary Vessels Oxygen medicine.anatomical_structure Endocrinology Constant pressure Arterial flow Vascular Resistance Cardiology and Cardiovascular Medicine Perfusion Artery medicine.drug |
| Zdroj: | The American journal of physiology. 266(5 Pt 2) |
| ISSN: | 0002-9513 |
| Popis: | The role of blocking ATP-sensitive potassium (KATP) channels by glibenclamide on the dynamic responses of coronary resistance to abrupt changes in perfusion pressure and heart rate was investigated. The left main coronary artery of the open-chest anesthetized goat was perfused with constant pressure (Pp). Pp and arterial flow were averaged per beat, and their ratio was calculated as index of coronary resistance. Responses of resistance index after heart rate (HR) and Pp changes before and after administration of glibenclamide were compared. Their rate of change was quantified by t50, the required time to obtain half of the complete response. During control, t50 for the dilating response induced by a decrease in Pp or increase in HR was 3.8 +/- 0.2 and 6.2 +/- 0.5 (SE) s, respectively. With glibenclamide these values were 24.4 +/- 1.6 and 14.9 +/- 2.1 s. For the constricting response, the numbers for control were 5.8 +/- 0.3 (increase Pp) and 7.2 +/- 0.8 (decrease HR) s. With glibenclamide these values were 22.1 +/- 1.5 and 16.0 +/- 2.9 s. The steady-state adjustment of coronary flow was not altered by glibenclamide. It was concluded that glibenclamide has a minor effect on coronary flow control but reduces the rate of change of coronary resistance index up to a factor of four. Because glibenclamide is supposed to act on KATP channels, it may be concluded that these channels play a major role in the dynamics of coronary blood flow regulation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|